Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

100%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
P 3 (2)

Trial Status

Not Yet Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT07531043Phase 3Not Yet RecruitingPrimary

Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

NCT07578363Phase 3Not Yet RecruitingPrimary

An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults

Showing all 2 trials

Research Network

Activity Timeline